کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2494722 1115577 2008 12 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب رفتاری
پیش نمایش صفحه اول مقاله
Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage
چکیده انگلیسی

Herein, we show that a single injection of P4 (4 mg/kg) at 1 h or 48 h, but not 96 h, before middle cerebral artery occlusion (MCAO) produces significant protective effects against the ischemia-induced neuronal death and the deficits in spatial cognition and LTP induction. The present study focused on the molecular mechanisms underlying the neuroprotection exerted by P4 administration at 1 h and 48 h pre-MCAO, termed acute and delayed P4-neuroprotection, respectively. Pharmacology suggested that P4-receptor (P4R) cascading to a Src-ERK1/2 signaling mediated the delayed P4-neuroprotection. To support this, it was observed by anti-phosph-ERK1/2 immunoblots that a single injection of P4 triggered a P4R-mediated persistent increase in ERK1/2 phosphorylation and their nuclear translocation for 48 h. In contrast, the acute P4-neuroprotection did not depend on the P4R-mediated Src-ERK1/2 signaling. Instead, the acute P4-administration attenuated the NMDA-induced rise in the intracellular calcium concentration ([Ca2+]i) that may be a primary cause for MCAO-induced neuronal injury. This effect seemed to be exerted by an antagonism of σ1 receptor since the σ1 receptor antagonist NE100 perfectly mimicked the acute P4-neuroprotection and also attenuated the NMDA-induced [Ca2+]i increase. These findings suggest that the P4 neuroprotection involves two independent processes depending on the timing of P4 administration before MCAO: an acute protection by antagonizing σ1 receptor to inhibit NMDAr-Ca2+ influx and a delayed one by an activation of P4R-mediated Src-ERK signaling pathway.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neuropharmacology - Volume 55, Issue 2, August 2008, Pages 127–138
نویسندگان
, , , , , ,